Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Treasury Shares (2016 - 2025)

Vycor Medical has reported Treasury Shares over the past 14 years, most recently at $1033.0 for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $1033.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1033.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1033.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares was $103334.0 for Q4 2025 at Vycor Medical, roughly flat from $103334.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $103334.0 in Q1 2021 and troughed at -$103334.0 in Q4 2022.
  • The 5-year median for Treasury Shares is $103334.0 (2021), against an average of $39667.4.
  • The largest YoY upside for Treasury Shares was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $1033.0 in 2021, then changed by 0.0% to $1033.0 in 2022, then changed by 0.0% to $1033.0 in 2023, then changed by 0.0% to $1033.0 in 2024, then changed by 0.0% to $1033.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Treasury Shares are $1033.0 (Q4 2025), $1033.0 (Q3 2025), and $1033.0 (Q2 2025).